Healthcare
MicroPort raises HK$1.5bln in Hong Kong IPO
MicroPort raises HK$1.5bln in Hong Kong IPO
Proceeds will be used to develop new products, acquire businesses and expand company’s production facilities.
Shanghai Pharma to raise $1.2bln via HK IPO
Company to offer 25% stake to fund acquisition of rivals and sales networks.
Commentary
The strategic decarbonisation model for Hong Kong real estate
The survival playbook for the CEO amidst geopolitical conflicts
The succession shift: Redesigning wealth structures for the next generation
2026 biotech playbook: Hong Kong at the centre of China’s globalisation